ARCHIVES

PSA Velocity Poor Predictor Of Prostate Cancer Occurrence

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Cancer Groups Urge FDA To Spell Out Standards For Data Collection In Time-To-Progression Trials.

November 7, 2008

NCI Bioinformatics After Kenneth Buetow: Varmus Launches Fundamental Redesign

January 6, 2012

NCI Advisory Group, Other Cancer Meetings

August 19, 1983

Alimta/Cisplatin Chemotherapy Increased Overall Survival

June 29, 2012

Obey Continue Crusade On Carcinogenesis, Attack On DCCP, Shubik

April 1, 1977

Construction Grants Exclude City of Hope

September 20, 1985